Related Experiment Video
Updated: Apr 8, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.5K
[Neoadjuvant therapy may allow unresectable tumors becoming resectable]
1Service de chirurgie hépatobiliaire et transplantation hépatique, Centre hépatobiliaire, Hôpital Paul-Brousse, 12-14, avenue Paul-Vaillant-Couturier, 94800 Villejuif, France.
Bulletin Du Cancer
|June 30, 2015
Summary
For uncertain pancreatic cancer resectability, surgery is debated. This article argues for considering surgical intervention in such challenging cases.
Area of Science:
- Oncology
- Surgical Oncology
Context:
- Pancreatic cancer treatment involves complex decisions regarding surgical resectability.
- Initial assessment of resectability for pancreatic cancer can be uncertain, leading to varied clinical approaches.
Purpose:
- To present arguments supporting surgical intervention for pancreatic cancer when resectability is initially uncertain.
- To address the ongoing controversy surrounding the surgical management of borderline resectable pancreatic cancer.
Summary:
- This article explores the rationale for considering surgery even when the initial resectability of pancreatic cancer is in doubt.
- It highlights key arguments favoring surgical approaches in cases of uncertain resectability, challenging a universally conservative stance.
Impact:
- Provides a focused perspective on surgical candidacy for complex pancreatic cancer cases.
- Contributes to the ongoing discussion on optimizing treatment strategies for pancreatic cancer with uncertain resectability.
Related Concept Videos
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K